Placebo effects in children with autism spectrum disorder
Developmental Medicine & Child Neurology · 2023-10 · 65 (10) · 1316-1320
DOI: 10.1111/dmcn.15574 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 14.03.2023. Verfasst von Aurore Curie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Reference Center for Intellectual Disability from Rare Causes, Department of Child Neurology, Woman Mother and Child Hospital, Hospices Civils de Lyo…. Hauptthemen laut MEDLINE: Placebo Effect, Autism Spectrum Disorder. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Placebo responses are frequently observed in research studies and clinical contexts, yet there is limited knowledge about the placebo effect among children with neurodevelopmental disorders. Here, we review the placebo effect in autism spectrum disorder (ASD). Placebo responses are widely evident in ASD clinical trials and could partly operate via so‐called placebo‐by‐proxy, whereby caregivers or clinicians indirectly shape patient outcomes. Understanding the role of placebo effects in ASD may help discern genuine treatment effects from contextual factors in clinical trials. The much less studied nocebo effect, or negative placebo, might contribute to the experience of side effects in ASD treatments but empirical data is missing. Better knowledge about placebo and nocebo mechanisms may contribute to the development of more effective research designs, such as three‐armed designs that account for natural history, and improved treatments for ASD symptoms. At a clinical level, deeper knowledge about placebo and nocebo effects may optimize the delivery of care for individuals with ASD in the future. What this paper adds Placebo responses are evident in autism spectrum disorder (ASD) clinical trials. Placebo responses in ASD are likely dependent on a placebo‐by‐proxy mechanism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Reference Center for Intellectual Disability from Rare Causes, Department of Child Neurology, Woman Mother and Child Hospital, Hospices Civils de Lyon, Bron, France.
- Department of Pediatrics and School of Population and Public Health, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada.
- Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
ORCID-Profile: Tim F Oberlander, Karin B Jensen
Zitieren
APA
Curie, A., Oberlander, T. F., & Jensen, K. B. (2023). Placebo effects in children with autism spectrum disorder. Developmental Medicine & Child Neurology, 65(10), 1316-1320. https://doi.org/10.1111/dmcn.15574
Vancouver
Curie A, Oberlander TF, Jensen KB. Placebo effects in children with autism spectrum disorder. Developmental Medicine & Child Neurology. 2023;65(10):1316-1320. doi:10.1111/dmcn.15574
BibTeX
@article{Curie2023,
author = {Curie, Aurore and Oberlander, Tim F and Jensen, Karin B},
title = {Placebo effects in children with autism spectrum disorder},
journal = {Developmental Medicine & Child Neurology},
year = {2023},
volume = {65},
number = {10},
pages = {1316--1320},
doi = {10.1111/dmcn.15574}
}
EUVIMED